lu 177 ca - Isotopia

Breaking news !

Lu177 is better than cabazitaxel in patients with metastatic castration-resistant prostate cancer. An unblinded, randomized phase 2 trial at 11 centers in Australia. the researchers

Read More »
proPSMA studies - Isotopia

proPSMA study

The “proPSMA” study results proved the superiority of 68Ga-PSMA imaging over conventional imaging with CT and Bone Scan in Prostate Cancer Results from a randomised

Read More »
18f dopa use in parkinsonism - Isotopia

18F-DOPA use in Parkinsonism On October 10, 2019, the FDA approved the use of 18F-DOPA in positron emission tomography to visualize dopaminergic nerve terminals in the striatum for

Read More »